{
    "clinical_study": {
        "@rank": "10040", 
        "arm_group": {
            "arm_group_label": "Cohort 1"
        }, 
        "brief_summary": {
            "textblock": "This study aims to evaluate off-label XGEVA use in Denmark using data linked from registries\n      and other sources in Northern Jutland Region of Denmark. This will allow for accurate\n      assessment of prescriptions and diagnoses, especially those related to cancer patients\n      during the first year post the initial market availability of XGEVA."
        }, 
        "brief_title": "Estimation of Off-Label Use of XGEVA\u00ae (Denosumab) Using Population-Based Databases in Denmark", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "XGEVA Off-label Use", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The study will include patients with a prescription for XGEVA\u00ae given in secondary\n             care with a maximum of 200 XGEVA users, in the Northern Jutland Region of Denmark\n             during the first 1-year post XGEVA market availability, defined as 12 months after\n             RADS opinion on 24th January 2013.\n\n        Exclusion Criteria:\n\n          -  n/a"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The study population will include 108-200 patients who receive a prescription in secondary\n        care of XGEVA during the first year after the initial market availability. These patients\n        will be identified from the Danish National Registry of Patients in the Northern Jutland\n        Region of Denmark."
            }
        }, 
        "enrollment": {
            "#text": "108", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02066805", 
            "org_study_id": "20101335"
        }, 
        "intervention": {
            "arm_group_label": "Cohort 1", 
            "description": "No intervention is planned during this study as it involves analyses of patient electronic records from Northern Jutland Region of Denmark", 
            "intervention_name": "Database assesssment of off-label XGEVA use", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 19, 2014", 
        "link": {
            "description": "AmgenTrials clinical trials website", 
            "url": "http://www.amgentrials.com"
        }, 
        "number_of_groups": "1", 
        "official_title": "Estimation of Off-Label Use of XGEVA\u00ae (Denosumab) Using Population-Based Databases in Denmark", 
        "overall_official": {
            "affiliation": "Amgen", 
            "last_name": "MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Denmark:Danish Data Protection Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Yes/no regarding whether an individual prescription was on (or off) label", 
                "measure": "on or off label individual prescription type", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Yes/no regarding whether the patient was treated on (or off) label", 
                "measure": "on or off label patient treatment", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02066805"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "XGEVA prescription for each type of off-label use", 
                "measure": "type of off-label use", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Prescriptions that are for off-label use stratified by department that administers treatment", 
                "measure": "off-label use stratified by administering department", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Amgen", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Aarhus", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Amgen", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}